Listening for Leisure After Stroke
MELLO
Measuring the Effects of Listening for Leisure on Outcome After Stroke (MELLO)
1 other identifier
interventional
100
1 country
1
Brief Summary
Stroke is the biggest cause of disability in older adults. Early poststroke rehabilitation focuses primarily on physical disability and activities of daily living. By contrast, relatively little research attention has been paid to the potential for cognitive rehabilitation and mood enhancing interventions in the early stages after stroke. Low mood and cognitive difficulties with attention and memory are common post stroke leading to poorer recovery, emotional wellbeing and quality of life yet accessible and effective therapies are lacking. Engagement in leisure activities may enhance recovery after stroke but participation in leisure activities is reduced following stroke. Music listening is a low cost and accessible leisure activity that has been suggested to improve mood and cognition poststroke. The investigators speculate that music listening may enhance control of attention in a similar way to mindfulness interventions, that have been demonstrated to be beneficial in the treatment of mood disorders. The investigators propose that adding a brief mindfulness intervention to music listening might enhance the effect on control of attention, with positive effects on cognition and mood poststroke but the feasibility and acceptability of this intervention needs to be evaluated before attempting a further trial assessing the effectiveness of this intervention. The investigators aim to recruit 100 patients within two weeks poststroke. Participants will be randomly assigned to receive an 8 week music listening alone, music listening with brief mindfulness or audiobook listening intervention alongside treatment as usual. Neuropsychological assessment of cognition and mood will be performed at baseline, 3 months, and 6 months poststroke In addition, participants will be interviewed about their experience of engaging in the interventions.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable stroke
Started Oct 2014
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2014
CompletedFirst Submitted
Initial submission to the registry
October 3, 2014
CompletedFirst Posted
Study publicly available on registry
October 8, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2016
CompletedJuly 6, 2016
July 1, 2016
1.9 years
October 3, 2014
July 5, 2016
Conditions
Outcome Measures
Primary Outcomes (3)
Recruitment rate at 6 month follow up from baseline
6 months
Treatment adherence at 6 month follow up from baseline
6 months
sample retention at 6 month follow up from baseline
6 months
Secondary Outcomes (8)
Change in overall cognition score at 6 months from baseline
6 months
Change in attention, memory and executive function scores at 6 months from baseline
6 months
Change in Hospital Anxiety and Depression Scale (HADS) scores at 6 months from baseline
6 months
Changes in Five Facet Mindfulness Questionnaire short form (FFMQ-sf)
6 months
Changes in Mayo Portland Adaptability Inventory 4 (MPAI-4) scores
6 months
- +3 more secondary outcomes
Study Arms (3)
Music listening
ACTIVE COMPARATORMusic listening with brief mindfulness
EXPERIMENTALAudio book intervention
PLACEBO COMPARATORInterventions
Music listening with mindfulness therapy
Eligibility Criteria
You may qualify if:
- Diagnosis of Ischaemic stroke (confirmed clinically and/or radiologically and subclassified according to the Oxford Clinical Stroke Classification)
- ≤14 days poststroke at time of recruitment (expression of interest to participate either verbally or in writing)
- Native English speaking
You may not qualify if:
- Comorbid progressive neurological or neurodegenerative condition
- History of major substance abuse problems
- Unable to give informed consent
- Unable to cooperate with the study protocol (e.g. due to severe aphasia, uncorrected impairment of hearing or vision, or illiteracy)
- Clinically unstable (e.g. due to major intercurrent illness).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- NHS Greater Glasgow and Clydelead
- University of Glasgowcollaborator
Study Sites (1)
NHS Greater Glasgow and Clyde
Glasgow, United Kingdom
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jonathan Evans, BSc,Dip.Clin.Psychol. PhD
University of Glasgow
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 3, 2014
First Posted
October 8, 2014
Study Start
October 1, 2014
Primary Completion
September 1, 2016
Study Completion
September 1, 2016
Last Updated
July 6, 2016
Record last verified: 2016-07